Bryn Mawr Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bryn Mawr Capital Management's LLY Position: Q2 2026 in Review
Bryn Mawr Capital Management reduced its Eli Lilly (LLY) stake by 0.79% in Q2 2026, selling an estimated $27.6K and leaving 3,407 shares worth $4.09M. The position accounts for 0.18% of the portfolio, ranked #115.
Bryn Mawr Capital Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.82M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bryn Mawr Capital Management held 3,407 shares of Eli Lilly worth $4.09M as of Q2 2026.
- Bryn Mawr Capital Management sold 27 Eli Lilly shares in Q2 2026, an estimated $27.6K.
- Eli Lilly made up 0.18% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #115 holding.
- Bryn Mawr Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- Bryn Mawr Capital Management's Eli Lilly position peaked at $4.82M in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.